Linkedin
en
fr

Accelerating oncology innovation through preclinical in
vitro studies and scientific & regulatory consulting

Accelerating oncology innovation through preclinical in vitro studies and scientific & regulatory consulting

Explore Lab Services

Etiam sed efficitur tristique at id ipsum ornare. Turpis congue inceptos per pellentesque netus.

Service Detail

Explore Consulting

Ornare adipiscing felis in potenti netus torquent scelerisque euismod tempor per curae.

Service Detail

Preclinical In Vitro Laboratory Services

Tailored pharmacology and oncology studies to answer key preclinical questions, with a strong focus on cancer biology, tumor immunology, tumor microenvironment, drug pharmacology, toxicology, efficacy, mechanism of action and translational relevance.

Our capabilities include:

  • Cell-Based Assays: cytotoxicity, survival, migration, invasion
  • 3D Tumor Models & Co-Culture Systems
  • Flow Cytometry
  • Imaging
  • Molecular Biology: PCR, RT-PCR, Western blot, ELISA
  • Gene/Protein Expression & Transfection
  • Study design & Protocols: experimental model selection, protocol design, method development
  • Data Analysis & Interpretation

Scientific & Regulatory Consulting

From scientific vision to regulatory approval, we combine deep oncology expertise with hands-on regulatory experience across EMA/FDA pathways.
Our consulting services cover:

Scientific & Research

  • Identification of trends, medical needs, gaps, and therapeutic opportunities
  • Market analysis (market size and segmentation, competitive landscape, regulatory context, adoption potential)
  • Development of R&D strategies
  • Building and supporting strategic partnerships
  • Cancer biology research, target and biomarker identification, drug mechanism-of-action assessment
  • Design of preclinical trials (toxicology, efficacy, pharmacodynamics, pharmacokinetics) in compliance with regulatory guidelines
  • Writing scientific articles and preparing visual materials

Funding & Grant Support

  • Eligibility checks
  • Proposal writing and submission for public and private funding opportunities

Regulatory & Compliance

  • Preparation of regulatory documents: Investigational Brochure (IB), Investigational New Drug Application (IND), Clinical Trial Application (CTA), Orphan Drug Designation (ODD), Scientific Advice requests
  • Submission of dossiers to regulatory authorities

Ready to accelerate your oncology program?

Tell us about your project – we’ll propose a tailored plan across laboratory studies & regulatory milestones.

Request a quote